CBLL Total Utang marang Modal CeriBell

Lambang korporat lan logo CeriBell (CBLL)

The CeriBell, Inc. (CBLL) total debt-to-equity ratio chart stands at 0.16. Stable business revenue is secured by linking medical centers to proprietary consumables for EEG systems. Further growth relies on insurance companies recognizing monitoring effectiveness and the implementation of AI in intensive care units. High demand for rapid stroke diagnostic software allows the company to maintain its pricing power.

CBLL: Total Utang marang Modal CeriBell 12.10.2024 - 28.10.2026

Rincian analitis lan laporan data perusahaan CeriBell EEG (CBLL)

- rega lan prakiraan konsensus rega:
Bagan rega CeriBell|CBLL - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Kapitalisasi pasar CeriBell|CBLL - Total Nilai Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi saben Saham CeriBell|CBLL - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku ceribell.com|CBLL - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas CeriBell, Inc.|CBLL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal CeriBell, Inc.|CBLL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku CeriBell
Analisis dhasar perusahaan:CeriBell CBLL
Sampel barang CeriBell EEG

This ratio is calculated as total liabilities divided by equity, measuring the business's degree of dependence on borrowed funds. The metric's trend depends directly on the balance sheet structure and the volume of raised financing. By analyzing the current leverage ratio (total debt to equity), an investor assesses the risk of bankruptcy or the potential for expansion. For CeriBell, Inc. (CBLL), this is critical when scaling its AI brain diagnostic system. Optimal leverage will allow CeriBell, Inc. (CBLL) to implement innovative EEG sensors without threatening its financial stability.

Pesaing wigati

Utang marang Ekuitas Biogen (BIIB)|Rasio Utang marang Ekuitas Neurocrine|Regencell - Total Utang marang Modal|Utang marang Modal Axsome Corp AXSM|Rasio Total Utang marang Ekuitas ACAD (ACADIA Pharmaceuticals)|xenon-pharma.com - Total Utang marang Modal|Utang marang Ekuitas Viking Therapeutics, Inc. (VKTX)|SUPN: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas CPRX|Denali Corp (DNLI) - Utang marang Modal|Total Utang marang Modal HRMY|Rasio Total Utang marang Ekuitas biohavenpharma.com|Amylyx Pharmaceuticals, Inc. - Total Utang marang Modal|Utang marang Modal TRVI (Trevi Therapeutics Inc)|Utang marang Ekuitas Praxis Medicines|Rasio Kabeh Utang marang Dana Pribadi Anavex Life Sciences Corp AVXL|Total Utang marang Modal PRTA (Prothena Corporation plc)|ALEC - Koefisien Total Utang marang Modal|Annexon (ANNX) - Total Utang marang Modal|Omeros (OMER) - Utang marang Ekuitas|Total Utang marang Modal NGNE (Neurogene Corp)|Utang marang Modal ACIU|Utang marang Ekuitas Voyager Therapeutics (VYGR)|Utang marang Ekuitas NMRA (neumoratx.com)|Utang marang Ekuitas Scilex SCLX|TVGN - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Alpha Cognition Corp (ACOG)|CGTX - Rasio Kabeh Utang marang Dana Pribadi|Inhibikase Therapeutics - Total Utang marang Modal|SAVA (cassavasciences.com) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Assertio Holdings (ASRT)|Rasio Utang marang Ekuitas Coya|Total Utang marang Modal VTGN (Vistagen Therapeutics)|Rasio Total Utang marang Ekuitas ovidrx.com OVID|Rasio Total Utang marang Ekuitas ABOS|Koefisien Total Utang marang Modal cervomed.com CRVO|ATHE: Total Utang marang Modal|CLNN - Rasio Total Utang marang Ekuitas|pepgen.com (PEPG) - Total Utang marang Modal|JUNS (Jupiter Neurosciences, Inc.) - Utang marang Ekuitas|Utang marang Ekuitas Relmada Therapeutics|Utang marang Ekuitas ANVS|Utang marang Ekuitas Grace Therapeutics, Inc. (GRCE)|Utang marang Ekuitas AIFF (Firefly Neuroscience, Inc.)|KLTO - Utang marang Ekuitas|Rasio Utang marang Ekuitas NeuroSense Therapeutics Ltd NRSN|RVPH (Reviva Pharmaceuticals) - Total Utang marang Modal|MetaVia Inc (MTVA) - Utang marang Modal|NRXS: Rasio Total Utang marang Ekuitas|HSDT (Helius Medical Technologies) - Total Utang marang Modal|PASG - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi NEUP|Minerva Neurosciences - Utang marang Ekuitas|Utang marang Modal athira.com (ATHA)|Addex Therapeutics Ltd - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Alzamend Neuro Inc. ALZN|CYCN (Cyclerion) - Total Utang marang Modal|PTIX: Utang marang Modal|Utang marang Ekuitas pasitheaclinics.com KTTA|Cortigent (CRGT) - Rasio Kabeh Utang marang Dana Pribadi|ATXI: Total Utang marang Modal|Koefisien Total Utang marang Modal Brainstorm Cell Therapeutics Inc.|Total Utang marang Modal Cara Therapeutics, Inc (CARA)|Utang marang Ekuitas Chromocell (CHRO)|ELYM: Total Utang marang Modal|Intra-Cellular Therapies Inc. - Utang marang Modal|LBPH - Utang marang Ekuitas|MRNS: Utang marang Ekuitas|NKGen (NKGN) - Utang marang Ekuitas|Utang marang Ekuitas NeuroBo Pharma|SAGE - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi synaptogen.com|TRVN (Trevena) - Total Utang marang Modal|Koefisien Total Utang marang Modal VIGL (vigilneuro.com)|WENA - Utang marang Ekuitas|Rasio Utang marang Ekuitas Cerevel Corp CERE